These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15747431)

  • 21. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
    Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
    HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
    Llibre JM; Clotet B
    AIDS Rev; 2012; 14(3):168-78. PubMed ID: 22833060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-exposure prophylaxis works--it's time to deliver.
    Beyrer C; Bekker LG; Pozniak A; Barré-Sinoussi F
    Lancet; 2015 Apr; 385(9977):1482-4. PubMed ID: 25933264
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 25. European Commission approves Atripla.
    AIDS Patient Care STDS; 2008 Jan; 22(1):87-8. PubMed ID: 18453042
    [No Abstract]   [Full Text] [Related]  

  • 26. Triple combinations regimens for HIV.
    Lancet Infect Dis; 2003 Nov; 3(11):682. PubMed ID: 14603888
    [No Abstract]   [Full Text] [Related]  

  • 27. Preexposure prophylaxis reduces HIV risk in injection-drug users.
    Rosenberg K
    Am J Nurs; 2013 Sep; 113(9):17. PubMed ID: 23985594
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia.
    Quach H; Lee LY; Smith B; Korman T; Woolley IJ
    AIDS; 2012 Sep; 26(15):1977-9. PubMed ID: 22992580
    [No Abstract]   [Full Text] [Related]  

  • 29. The introduction of new antiretroviral-based HIV prevention methods into health systems: an update.
    Daly F
    Reprod Health Matters; 2012 Jun; 20(39):215. PubMed ID: 22789099
    [No Abstract]   [Full Text] [Related]  

  • 30. Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals.
    Scourfield A; Zheng J; Chinthapalli S; Waters L; Martin T; Mandalia S; Nelson M
    AIDS; 2012 Jul; 26(11):1399-401. PubMed ID: 22441251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of adherence and efficiency when replacing an antiretroviral therapy with efavirenz-emtricitabine-tenofovir in a single daily dose].
    García-Ramos SE; Santolaya Perrín MR; Fernández-Pacheco García-Valdecasas M
    Farm Hosp; 2012; 36(5):315-20. PubMed ID: 22858089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1].
    Oyagüez I; Casado MA; Cotarelo M; Ramírez-Arellano A; Mallolas J
    Farm Hosp; 2009; 33(5):247-56. PubMed ID: 19775575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preexposure prophylaxis for HIV infection--current data and recommendations].
    Kümmerle T; Fätkenheuer G
    Dtsch Med Wochenschr; 2012 Nov; 137(44):2285-8. PubMed ID: 23093400
    [No Abstract]   [Full Text] [Related]  

  • 34. Hopes dashed for formulation.
    AIDS Patient Care STDS; 2005 Oct; 19(10):696. PubMed ID: 16283698
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir.
    AIDS Alert; 2009 Nov; 24(11):130. PubMed ID: 19960612
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiretrovirals for HIV prevention: translating promise into praxis.
    Mayer KH
    Lancet; 2011 Jul; 378(9787):206-8. PubMed ID: 21763922
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lipid profile and body fat--significant "side effect" of antiretroviral therapy. Tenofovir: favorable profile of adverse effects].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():83. PubMed ID: 15011603
    [No Abstract]   [Full Text] [Related]  

  • 38. Painless penile papule.
    Marszalek RM; Bae-Harboe YS; Mahalingam M; Masterpol K
    J Fam Pract; 2015 Mar; 64(3):185-8. PubMed ID: 25789346
    [No Abstract]   [Full Text] [Related]  

  • 39. Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era.
    De Clercq E
    Biochem Pharmacol; 2012 Aug; 84(3):241-8. PubMed ID: 22504027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efavirenz and psychosis: is there a link?
    Manning TG
    Aust N Z J Psychiatry; 2012 Jul; 46(7):687-8. PubMed ID: 22735641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.